GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
Foundation pledges help for low income couples with infertility
Hope of becoming parents brightened for low income Nigerian couples with infertility problem on Tuesday following the launch of a Foundation with a mandate to assist them in accessing medically-assisted
Diphtheria: Kano govt activates contact tracing as over 100 hospitalized, 2,000 others discharged
The Kano State government says it has activated contact tracing teams to trace patients affected by diphtheria outbreak in the state as more than 100 patients were on admission and
NHO holds media Roundtable Conference on diabetes
… Countdown begins on 2016 World Health Day activities To mark the 2016 World Health Day (WHD), Africa’s premier health online newspaper, Nigeria Health Online (NHO) is organizing a media
0 Comments
No Comments Yet!
You can be first to comment this post!